These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12612815)

  • 1. The hand in Smith-Magenis syndrome (deletion 17p11.2): evaluation by metacarpophalangeal pattern profile analysis.
    Schlesinger AE; Potocki L; Poznanski AK; Lupski JR
    Pediatr Radiol; 2003 Mar; 33(3):173-6. PubMed ID: 12612815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurologic and developmental features of the Smith-Magenis syndrome (del 17p11.2).
    Gropman AL; Duncan WC; Smith AC
    Pediatr Neurol; 2006 May; 34(5):337-50. PubMed ID: 16647992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Smith-Magenis syndrome].
    Livet MO; Moncla A; Delobel B; Croquette MF; Philip N; Vallée L
    Arch Pediatr; 1997 Dec; 4(12):1231-7. PubMed ID: 9538429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metacarpophalangeal profile pattern analysis in a further patient with a novel ARID1B variant.
    Pascolini G
    Congenit Anom (Kyoto); 2021 Sep; 61(5):193-196. PubMed ID: 34056762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic hand anomalies in Smith-Magenis syndrome: four new patients with del (17)(p11.2p11.2).
    Kondo I; Matsuura S; Kuwajima K; Tokashiki M; Izumikawa Y; Naritomi K; Niikawa N; Kajii T
    Am J Med Genet; 1991 Nov; 41(2):225-9. PubMed ID: 1785639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refinement of the Smith-Magenis syndrome critical region to approximately 950kb and assessment of 17p11.2 deletions. Are all deletions created equally?
    Vlangos CN; Yim DK; Elsea SH
    Mol Genet Metab; 2003 Jun; 79(2):134-41. PubMed ID: 12809645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmic manifestations of Smith-Magenis syndrome.
    Chen RM; Lupski JR; Greenberg F; Lewis RA
    Ophthalmology; 1996 Jul; 103(7):1084-91. PubMed ID: 8684798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and delineation of an unusual 17p11.2 deletion by array-CGH and refinement of the Smith-Magenis syndrome minimum deletion to approximately 650 kb.
    Schoumans J; Staaf J; Jönsson G; Rantala J; Zimmer KS; Borg A; Nordenskjöld M; Anderlid BM
    Eur J Med Genet; 2005; 48(3):290-300. PubMed ID: 16179224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient with large 17p11.2 deletion presenting with Smith-Magenis syndrome and Joubert syndrome phenotype.
    Natacci F; Corrado L; Pierri M; Rossetti M; Zuccarini C; Riva P; Miozzo M; Larizza L
    Am J Med Genet; 2000 Dec; 95(5):467-72. PubMed ID: 11146468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epilepsy and chromosomal rearrangements in Smith-Magenis Syndrome [del(17)(p11.2p11.2)].
    Goldman AM; Potocki L; Walz K; Lynch JK; Glaze DG; Lupski JR; Noebels JL
    J Child Neurol; 2006 Feb; 21(2):93-8. PubMed ID: 16566870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Smith-Magenis syndrome: report of one case.
    Hou JW
    Acta Paediatr Taiwan; 2003; 44(3):161-4. PubMed ID: 14521023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Speech impairment and the Smith-Magenis syndrome].
    Bergmann C; Morlot S; Ptok M
    HNO; 2007 Aug; 55(8):644-6. PubMed ID: 16767429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New developments in Smith-Magenis syndrome (del 17p11.2).
    Gropman AL; Elsea S; Duncan WC; Smith AC
    Curr Opin Neurol; 2007 Apr; 20(2):125-34. PubMed ID: 17351481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral phenotype of Smith-Magenis syndrome (del 17p11.2).
    Smith AC; Dykens E; Greenberg F
    Am J Med Genet; 1998 Mar; 81(2):179-85. PubMed ID: 9613859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polydactyly in a boy with Smith-Magenis syndrome.
    MarianneJensen L; Kirchhoff M
    Clin Dysmorphol; 2005 Oct; 14(4):189-190. PubMed ID: 16155420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microdeletion on 17p11.2 in a Smith-Magenis syndrome patient with mental retardation and congenital heart defect: first report from China.
    Huang C; Yang YF; Zhang H; Xie L; Chen JL; Wang J; Tan ZP; Luo H
    Genet Mol Res; 2012 Aug; 11(3):2321-7. PubMed ID: 22911601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smith-Magenis syndrome and growth hormone deficiency.
    Spadoni E; Colapietro P; Bozzola M; Marseglia GL; Repossi L; Danesino C; Larizza L; Maraschio P
    Eur J Pediatr; 2004 Jul; 163(7):353-8. PubMed ID: 15138811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Turkish patient with large 17p11.2 deletion presenting with Smith Magenis syndrome.
    Tug E; Cine N; Aydin H
    Genet Couns; 2011; 22(1):11-9. PubMed ID: 21614983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and adaptive behavior profiles in Smith-Magenis syndrome.
    Madduri N; Peters SU; Voigt RG; Llorente AM; Lupski JR; Potocki L
    J Dev Behav Pediatr; 2006 Jun; 27(3):188-92. PubMed ID: 16775514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Definition of the critical interval for Smith-Magenis syndrome.
    Elsea SH; Purandare SM; Adell RA; Juyal RC; Davis JG; Finucane B; Magenis RE; Patel PI
    Cytogenet Cell Genet; 1997; 79(3-4):276-81. PubMed ID: 9605871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.